Research News and Research

RSS

Biomarker predicts bipolarity in depressed patients

Measuring plasma levels of brain-derived neurotrophic factor in patients with a first episode of depression could help to predict who will go on to develop bipolar disorder, research suggests.

7 May 2014

Insurers say most Obamacare enrollees pay first premium

But they say the eight million enrollment figure includes many duplicate signups, The New York Times reports. News outlets also report on a health law provision that extends Medicaid coverage for former foster children until they turn 26.

7 May 2014

New e.p.t Preconception Health Test to be available for reducing risk of preterm labor

Today, e.p.t − creator of the original home pregnancy test − announced the introduction of the e.p.t Preconception Health Test, a revolutionary new product that once again puts women in control of their personal health.

7 May 2014

Rigel Pharmaceuticals reports net loss of $22.3 million for first quarter 2014

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2014.

7 May 2014

Covidien opens new facility in Turkey to expand training and research capabilities

Further expanding its training and research capabilities in emerging markets, Covidien plc (NYSE: COV), has officially opened its Covidien Center of Innovation Turkey (CCI Turkey).

7 May 2014

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Lipids, primarily cholesterol and triglycerides, come from two sources: what is naturally manufactured in the liver and what comes from the intestines through the diet.

From Sanofi 7 May 2014

Evogene reports operating loss of $2.6M in first quarter 2014

Evogene Ltd., a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today its financial results for the quarter ended March 31, 2014.

7 May 2014

LifeMap Solutions focuses on creating innovative mobile health products

LifeMap Solutions, Inc., a medical technology startup focused on creating innovative mobile health (mHealth) products and services powered by big data, today announced an initial $5 million seed round led by parent company LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., with additional participation via in-kind support from its development partner, the Icahn School of Medicine at Mount Sinai.

7 May 2014

Targacept reports net loss of $11.6M in first quarter 2014

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the first quarter ended March 31, 2014.

7 May 2014

ARIAD provides update on corporate developments, reports Q1 2014 financial results

ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.

7 May 2014

NexID offers liveness detection software for fingerprint-sensors on mobile devices

NexID Biometrics LLC, the first company to offer liveness detection software for fingerprint-sensors on mobile devices, today launched its Mobile Live Finger Detection (LFD) application for the Android operating system.

7 May 2014

Breastfeeding promotes growth of beneficial lactic acid bacteria in baby's gut flora

The nutritional factor that has the greatest impact on the development of a child's gut flora is whether the child is breastfed, according to a new study by the National Food Institute, Technical University of Denmark, and the University of Copenhagen.

7 May 2014

Research on how heart rate increases in response to alertness in brain

George Washington University (GW) researcher David Mendelowitz, Ph.D., was recently published in the Journal of Neuroscience for his research on how heart rate increases in response to alertness in the brain.

7 May 2014

ArQule reports net loss of $7,141,000 in first quarter 2014

ArQule, Inc. today announced its financial results for the first quarter of 2014. For the quarter ended March 31, 2014, the Company reported a net loss of $7,141,000 or $0.11 per share, compared to a net loss of $5,775,000, or $0.09 per share, for the first quarter of 2013.

7 May 2014

First reversible glue to treat eye injuries of soldiers

Scientists have developed the first reversible glue that could be used on the battlefield to treat eye injuries, potentially saving soldiers' vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.

7 May 2014

Perfusion system at room temperature preserves and improves metabolic function of donor livers

A system developed by investigators at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine (CEM) and the MGH Transplant Center has the potential to increase both the supply and the quality of donor organs for liver transplantation.

7 May 2014

Research News and Research

Biomarker predicts bipolarity in depressed patients

Insurers say most Obamacare enrollees pay first premium

New e.p.t Preconception Health Test to be available for reducing risk of preterm labor

Rigel Pharmaceuticals reports net loss of $22.3 million for first quarter 2014

Covidien opens new facility in Turkey to expand training and research capabilities

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Evogene reports operating loss of $2.6M in first quarter 2014

LifeMap Solutions focuses on creating innovative mobile health products

Targacept reports net loss of $11.6M in first quarter 2014

ARIAD provides update on corporate developments, reports Q1 2014 financial results

NexID offers liveness detection software for fingerprint-sensors on mobile devices

Breastfeeding promotes growth of beneficial lactic acid bacteria in baby's gut flora

Research on how heart rate increases in response to alertness in brain

ArQule reports net loss of $7,141,000 in first quarter 2014

First reversible glue to treat eye injuries of soldiers

Perfusion system at room temperature preserves and improves metabolic function of donor livers

Biovision's program to focus on economic, business challenges faced by life sciences industry

New research reveals surprising facts about players who mask their identity online

Regression occurs more often in black and Hispanic children compared to whites

State highlights: N.D. kids' program eligibility; Conn. nursing home transparency; La. hospital privatization

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy